Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention (Q37973223)

From Wikidata

Jump to navigation Jump to search

scientific article published on 04 January 2012

Language	Label	Description	Also known as
English	Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention	scientific article published on 04 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention (English)

1 reference

Europe PubMed Central

26 August 2017

0 references

personalized medicine

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

J H Meyer

1

1 reference

Europe PubMed Central

26 August 2017

language of work or name

0 references

publication date

4 January 2012

1 reference

Europe PubMed Central

26 August 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

26 August 2017

91

1 reference

Europe PubMed Central

26 August 2017

2

1 reference

Europe PubMed Central

26 August 2017

201-214

1 reference

Europe PubMed Central

26 August 2017

https://scigraph.springernature.com/pub.10.1038/clpt.2011.285

0 references

Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The therapeutic potential of monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Applying neuroimaging ligands to study major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Neural mechanisms mediating optimism bias

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The neural basis of loss aversion in decision-making under risk

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated brain monoamine oxidase A binding in the early postpartum period

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Prospective study of postpartum blues. Biologic and psychosocial factors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Gliogenesis and glial pathology in depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

A hundred cases of suicide: clinical aspects.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

An overview of epidemiological studies on seasonal affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Seasonal variation in human brain serotonin transporter binding.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

PET imaging of serotonin 1A receptor binding in depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced serotonin type 1A receptor binding in panic disorder.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced serotonin-1A receptor binding in social anxiety disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Lower dopamine transporter binding potential in striatum during depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dopamine transporter binding in depressed patients with anhedonia.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Course of illness, hippocampal function, and hippocampal volume in major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Hippocampal atrophy in recurrent major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Cellular changes in the postmortem hippocampus in major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain serotonin2 receptors in major depression: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased 5-HT 2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [ 11 C]MDL 100,907

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2011.285

1 reference

Europe PubMed Central

26 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37973223&oldid=1735191272"